HIV-1 p30

HIV-1 p30 Recombinant
Cat. No.
BT22618
Source

Escherichia Coli.

Synonyms
Appearance

Sterile Filtered clear solution.

Purity

Protein is >95% pure as determined by 10% PAGE (coomassie staining).      

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant HIV-1 p30 produced in E. coli having a Mw of 30kDa. Recombinant HIV-1 p30 is fused to a 6xHis tag at its C-terminus and purified by proprietary chromatographic technique.

Product Specs

Description
Recombinant HIV-1 p30 produced in E. coli having a Mw of 30kDa. Recombinant HIV-1 p30 is fused to a 6xHis tag at its C-terminus and purified by proprietary chromatographic technique.
Physical Appearance
Sterile Filtered clear solution.
Formulation
HIV-1 p30 solution contains 25mM K2CO3 & PBS.
Stability
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
Purity
Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Applications
ELISA, WB & LFA.
Source

Escherichia Coli.

Product Science Overview

Introduction

HIV-1 p30 is a recombinant protein derived from the Human Immunodeficiency Virus type 1 (HIV-1). This protein is a part of the Gag polyprotein, which plays a crucial role in the assembly and maturation of the virus. The recombinant form of HIV-1 p30 is often used in research and vaccine development due to its immunogenic properties.

Structure and Function

The HIV-1 p30 protein is a segment of the larger Gag polyprotein, which also includes other important proteins such as p24, p17, and p7. The Gag polyprotein is essential for the formation of the viral core, which houses the viral RNA and enzymes necessary for replication. The p30 protein specifically contributes to the structural integrity of the virus and is involved in the assembly of the viral capsid.

Recombinant Production

Recombinant HIV-1 p30 is produced using various expression systems, such as bacterial, yeast, or mammalian cells. The gene encoding the p30 protein is cloned into an expression vector, which is then introduced into the host cells. These cells are cultured under conditions that promote the expression of the recombinant protein. The protein is subsequently purified using techniques like affinity chromatography.

Applications in Research and Medicine
  1. Vaccine Development: Recombinant HIV-1 p30 is used as an antigen in vaccine formulations. Its ability to elicit an immune response makes it a valuable component in the development of HIV vaccines.
  2. Diagnostic Tools: The protein is also used in diagnostic assays to detect HIV infection. Enzyme-linked immunosorbent assays (ELISAs) often utilize recombinant p30 to capture antibodies from patient samples.
  3. Immunological Studies: Researchers use recombinant p30 to study the immune response to HIV infection. This helps in understanding how the virus evades the immune system and in developing strategies to counteract it.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.